ATE360435T1 - Behandlung des schweren akuten atemwegssyndroms (sars) - Google Patents

Behandlung des schweren akuten atemwegssyndroms (sars)

Info

Publication number
ATE360435T1
ATE360435T1 AT04726957T AT04726957T ATE360435T1 AT E360435 T1 ATE360435 T1 AT E360435T1 AT 04726957 T AT04726957 T AT 04726957T AT 04726957 T AT04726957 T AT 04726957T AT E360435 T1 ATE360435 T1 AT E360435T1
Authority
AT
Austria
Prior art keywords
sars
acute respiratory
respiratory syndrome
treatment
severe acute
Prior art date
Application number
AT04726957T
Other languages
English (en)
Inventor
Leif Kongerslev
Dietmar Weilguny
Finn Matthiesen
Jens Christian Jensenius
Original Assignee
Natimmune As
Univ Aarhus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natimmune As, Univ Aarhus filed Critical Natimmune As
Application granted granted Critical
Publication of ATE360435T1 publication Critical patent/ATE360435T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/178—Lectin superfamily, e.g. selectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT04726957T 2003-04-09 2004-04-13 Behandlung des schweren akuten atemwegssyndroms (sars) ATE360435T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300549 2003-04-09
DKPA200300714 2003-05-10

Publications (1)

Publication Number Publication Date
ATE360435T1 true ATE360435T1 (de) 2007-05-15

Family

ID=33160905

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04726957T ATE360435T1 (de) 2003-04-09 2004-04-13 Behandlung des schweren akuten atemwegssyndroms (sars)

Country Status (6)

Country Link
US (1) US20050137126A1 (de)
EP (1) EP1615652B1 (de)
JP (1) JP2006522751A (de)
AT (1) ATE360435T1 (de)
DE (1) DE602004006108D1 (de)
WO (1) WO2004089394A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150152619A1 (en) * 2013-12-03 2015-06-04 Glaus, Pyle, Schomer, Burns & Dehaven, Inc. dba GPD Group Guy anchor remediation apparatus

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1539964B1 (de) * 2002-09-10 2006-12-27 Natlmmune A/S Collectin-komplement aktivierende proteinchimären
DE20317914U1 (de) 2003-11-19 2004-12-30 Weh, Erwin Betätigungsvorrichtung für eine Schnellanschlusskupplung
EP1833502B1 (de) * 2004-12-23 2011-03-02 Council of Scientific and Industrial Research Pharmazeutische zusammensetzung zur behandlung von invasiver lungenaspergillose
EP1830810A4 (de) * 2004-12-30 2011-02-02 Dobeel Co Ltd Sprühgetrocknete zusammensetzung mit proteinen der collectin-familie oder varianten davon und herstellungsverfahren dafür
CN1896272B (zh) * 2005-07-12 2010-04-14 中国人民解放军军事医学科学院放射与辐射医学研究所 一种检测SARS-CoV易感基因MBL基因型的试剂
EP2247846B1 (de) * 2008-01-16 2012-11-28 Superpar Otomotiv San. Ve Tic. A.S. Elektrische kraftstoffpumpe für hdep (heavy duty engine platforms - schwere motorenplattformen)
US20100331240A1 (en) * 2008-01-18 2010-12-30 The General Hospital Corporation Methods for prevention and treatment of infections with supraphysiological doses of mannan-binding lectin (mbl) and ficolin-mbl fusion proteins
SG11201400851PA (en) 2011-09-22 2014-04-28 Cytomatrix Pty Ltd Method for the ex vivo expansion of hematopoietic stem and progenitor cells
PL3773675T3 (pl) 2018-03-29 2025-03-03 Airway Therapeutics, Inc. Systemy i sposoby charakteryzowania oligomerów białka surfaktantowego D (SP-D)
CN115297884A (zh) * 2020-03-05 2022-11-04 普纽玛根有限公司 病毒感染的治疗
US20240307524A1 (en) * 2021-07-07 2024-09-19 Luxembourg Institute Of Health (Lih) Coronavirus vaccines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003018617A1 (en) * 2001-08-31 2003-03-06 Fuso Pharmaceutical Industries, Ltd. Method of purifying human mannose binding lectin, human mannose binding lectin compositions and medicinal use of human mannose binding lectin
US7135338B2 (en) * 2003-06-11 2006-11-14 Dobeel Corporation Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150152619A1 (en) * 2013-12-03 2015-06-04 Glaus, Pyle, Schomer, Burns & Dehaven, Inc. dba GPD Group Guy anchor remediation apparatus
US9359739B2 (en) * 2013-12-03 2016-06-07 Glaus, Pyle, Schomer, Burns & Delhaven, Inc. Guy anchor remediation apparatus

Also Published As

Publication number Publication date
DE602004006108D1 (de) 2007-06-06
WO2004089394A3 (en) 2005-08-25
WO2004089394A2 (en) 2004-10-21
US20050137126A1 (en) 2005-06-23
JP2006522751A (ja) 2006-10-05
EP1615652A2 (de) 2006-01-18
WO2004089394A8 (en) 2005-11-10
EP1615652B1 (de) 2007-04-25

Similar Documents

Publication Publication Date Title
ATE360435T1 (de) Behandlung des schweren akuten atemwegssyndroms (sars)
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
NO20061291L (no) Ny formulering
NO20083245L (no) Sykliske antimikrobielle peptider
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
CY1112790T1 (el) Χρηση μαγιας σεληνιου στην αντιμετωπιση της νοσου αλτσχαιμερ
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
ATE346585T1 (de) Kationische cassia-derivate und anwendungen dafür
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
EA201791701A1 (ru) Диспергируемые композиции
NO20061911L (no) Immunogene sammensetninger
DE60312211D1 (de) Haarbehandlungsmittel
ATE427116T1 (de) Behandlung von bakteriellen infektionen
NO20055741L (no) Nye kjemiske forbindelser
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
NO20044446L (no) Anvendelse av polymerer omfattende termoplastiske polymerer som filterhjelpemidler og/eller stabiliseringsmiddel
MY147371A (en) Composition containing oligosaccharides for the treatment / prevention of infections
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
DE60211495D1 (de) Xanthin-glycol-derivate zur behandlung des reizdarmsyndroms
NO20060420L (no) 2-aminobenzoylderivater
TR201900241T4 (tr) Vasoprotektif maddelerin kombinasyonları ve bunları içeren formülasyonlar.
NO20054670L (no) Behandling av intestinale tilstander med N-2,3,3-tetrametylbisyklo[2.2.1]-heptan-2-amid
ATE487485T1 (de) Verwendung von d-ribose zur behandlung von vorhofflimmern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties